Private Advisor Group LLC Reduces Holdings in Danaher Co. (DHR)

Private Advisor Group LLC cut its position in Danaher Co. (NYSE:DHR) by 27.2% in the 4th quarter, Holdings Channel reports. The firm owned 13,721 shares of the conglomerate’s stock after selling 5,131 shares during the period. Private Advisor Group LLC’s holdings in Danaher were worth $1,305,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Calton & Associates Inc. bought a new position in shares of Danaher during the fourth quarter worth about $114,000. GQG Partners LLC bought a new position in shares of Danaher during the second quarter worth about $101,000. First Personal Financial Services raised its position in shares of Danaher by 128.9% during the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after acquiring an additional 691 shares during the last quarter. Zions Bancorporation raised its position in shares of Danaher by 118.3% during the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after acquiring an additional 667 shares during the last quarter. Finally, Resources Investment Advisors Inc. raised its position in shares of Danaher by 661.2% during the fourth quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock worth $142,000 after acquiring an additional 1,329 shares during the last quarter. Hedge funds and other institutional investors own 77.05% of the company’s stock.

Shares of Danaher Co. (NYSE:DHR) opened at $97.54 on Monday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43. Danaher Co. has a one year low of $78.97 and a one year high of $104.82. The company has a market capitalization of $67,946.36, a P/E ratio of 24.20, a P/E/G ratio of 2.05 and a beta of 1.04.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $4.97 billion. During the same quarter last year, the firm posted $1.05 earnings per share. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. analysts forecast that Danaher Co. will post 4.37 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were paid a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.57%. Danaher’s dividend payout ratio (DPR) is presently 15.86%.

In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total value of $4,397,242.52. Following the completion of the sale, the senior vice president now owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the sale, the executive vice president now directly owns 270,523 shares of the company’s stock, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. Insiders sold 237,043 shares of company stock valued at $24,194,886 in the last three months. Insiders own 12.20% of the company’s stock.

DHR has been the subject of a number of analyst reports. Argus raised their price objective on Danaher from $100.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. Cowen restated a “buy” rating and set a $110.00 price objective on shares of Danaher in a research report on Tuesday, January 30th. Citigroup raised their price objective on Danaher to $107.00 and gave the stock a “buy” rating in a research report on Friday, December 15th. Royal Bank of Canada restated a “hold” rating and set a $98.00 price objective on shares of Danaher in a research report on Wednesday, January 31st. Finally, Credit Suisse Group restated a “hold” rating and set a $99.00 price objective on shares of Danaher in a research report on Tuesday, December 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $100.68.

TRADEMARK VIOLATION WARNING: This piece of content was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/02/19/private-advisor-group-llc-reduces-holdings-in-danaher-co-dhr.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply